<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">337834</id>
  <title nil="true"/>
  <common-name>3-[(9-bromoindolo[3,2-b]quinoxalin-6-yl)methyl]-4-(4-methoxyphenyl)-1h-1,2,4-triazole-5-thione</common-name>
  <description>3-[(9-bromoindolo[3,2-b]quinoxalin-6-yl)methyl]-4-(4-methoxyphenyl)-1h-1,2,4-triazole-5-thione is a chemical compound with the formula C24H17BrN6OS. With an average molecular weight of 517.40 g/mol, 3-[(9-bromoindolo[3,2-b]quinoxalin-6-yl)methyl]-4-(4-methoxyphenyl)-1h-1,2,4-triazole-5-thione is a heavy molecule.</description>
  <cas>109322-28-3</cas>
  <pubchem-id>3065969</pubchem-id>
  <chemical-formula>C24H17BrN6OS</chemical-formula>
  <weight>517.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T20:48:24Z</created-at>
  <updated-at type="dateTime">2026-08-30T20:48:24Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=CC=C(C=C1)N2C(=NNC2=S)CN3C4=C(C=C(C=C4)Br)C5=NC6=CC=CC=C6N=C53</moldb-smiles>
  <moldb-formula>C24H17BrN6OS</moldb-formula>
  <moldb-inchi>InChI=1S/C24H17BrN6OS/c1-32-16-9-7-15(8-10-16)31-21(28-29-24(31)33)13-30-20-11-6-14(25)12-17(20)22-23(30)27-19-5-3-2-4-18(19)26-22/h2-12H,13H2,1H3,(H,29,33)</moldb-inchi>
  <moldb-inchikey>JKAKKUDSNROZEE-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">516.03679</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.1</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM333727</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-[(9-bromoindolo[3,2-b]quinoxalin-6-yl)methyl]-4-(4-methoxyphenyl)-1h-1,2,4-triazole-5-thione</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Triazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0288263</sync-id>
  <structure-inchikey>JKAKKUDSNROZEE-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>400200020800040000000000000000010000000000200004000004000000040000002200000000000002000000400000000000000000000000000000000000000000000000000000000004000000000000100000200800000000208040000200000010040000008100000000400000100000000002000000000000000000040000000804000200000000004000000800100000000010000000000000000000000000000040000080000000000000000000000000000000000000080000000000000000000000100000000000000008000040820020200040000000040000040100001000040000000000000000000000000000040080004000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAhAAAAJgAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:38:48Z</structure-indexed-at>
</compound>
